iANTHUS CAPITAL HOLDINGS (ITHUF) Gross Margin (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Gross Margin came in at 47.51% in Q1 2026, down 201.0% year-on-year from 47.04% in Q1 2025, and up 11.15% quarter-over-quarter from 42.74% in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Gross Margin (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Gross Margin across 7 years of filings, most recently posting 47.51% for Q1 2026.
- Gross Margin for Q1 2026 came in at 47.51%, down 201.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 45.02% (down 177.0% YoY), and the FY2025 annual result was 45.63%, up 80.0% from the prior year.
- Gross Margin came in at 47.51% for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from 42.74% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 52.56% in Q1 2022 to a low of 31.12% in Q3 2023.
- The 5-year median for Gross Margin is 44.8% (2024), against an average of 44.14%.
- Across the five-year window, Gross Margin sank 1251 bps in 2022 and jumped 1377 bps in 2024, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Gross Margin stood at 42.83% in 2022, then fell by 9 bps to 38.94% in 2023, then climbed by 15 bps to 44.8% in 2024, then retreated by 5 bps to 42.74% in 2025, then gained by 11 bps to 47.51% in 2026.
- The last three Gross Margin figures came in at 47.51% (Q1 2026), 42.74% (Q4 2025), and 44.03% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 49.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 71.66% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 82.93% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 49.50% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 98.31% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.26% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -293.83% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 65.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 61.20% |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 47.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.51% |
| Dec 31, 2025 | 42.74% |
| Sep 30, 2025 | 44.03% |
| Jun 30, 2025 | 45.91% |
| Mar 31, 2025 | 49.52% |
| Dec 31, 2024 | 44.80% |
| Sep 30, 2024 | 44.89% |
| Jun 30, 2024 | 48.12% |
| Mar 31, 2024 | 41.38% |
| Dec 31, 2023 | 38.94% |
| Sep 30, 2023 | 31.12% |
| Jun 30, 2023 | 47.50% |
| Mar 31, 2023 | 42.21% |
| Dec 31, 2022 | 42.83% |
| Sep 30, 2022 | 41.10% |
| Jun 30, 2022 | 45.23% |
| Mar 31, 2022 | 52.56% |
| Dec 31, 2021 | 47.02% |
| Sep 30, 2021 | 52.89% |
| Jun 30, 2021 | 57.74% |